<DOC>
	<DOC>NCT00329901</DOC>
	<brief_summary>Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years</brief_summary>
	<brief_title>Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Meningitis, Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male and female 1125 years old healthy subjects; who had received the primary immunization with a vaccine containing DT or Tdap antigens and a T, Td, or Tdap booster injection at least 5 years prior to study entry previous ascertained or suspected disease caused by N. meningitidis previously been immunized with a meningococcal vaccine or vaccine containing meningococcal antigen(s) serious acute, chronic or progressive disease history of any anaphylaxis, serious vaccine reactions, or allergy to any vaccine component known or suspected impairment/alteration of immune function, either congenital or acquired</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Meningitis</keyword>
	<keyword>healthy subject</keyword>
	<keyword>vaccine</keyword>
</DOC>